Tuberculosis Market Research Reports & Industry Analysis
The Mantoux test is used in the United States and is endorsed by the American Thoracic Society and Centers for Disease Control and Prevention (CDC). Multiple puncture tests such as the Tine test are not recommended. The Mantoux test is one of the two major tuberculin skin tests for tuberculosis used in the world.
As a replacement for the Mantoux test, several other tests are being developed. QuantiFERON®-TB Gold, manufactured by Cellestis Limited (Carnegie, Victoria, Australia) is a blood test that measures the patient’s immune reactivity to the M. tuberculosis and is useful for initial and serial testing of persons with an increased risk of latent or active tuberculosis infection. Guidelines for the use of QuantiFERON-®TB Gold were released by the CDC in December of 2005. QuantiFERON®-TB Gold is FDA approved in the United States; has CE Mark approval in Europe; and has been approved by the MHLW in Japan. Sputum smears and cultures should be done for acid-fast bacilli if the patient is producing sputum. The preferred method for this is fluorescence microscopy (auramine-rhodamine staining), which is more sensitive than conventional Ziehl- Neelsen staining.
Tuberculosis Industry Research & Market Reports
-
Tuberculosis Testing Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application
... to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027. For geography segment, regional supply, demand, major players, price is presented from 2017 to 2027. ... Read More
-
2022-2026 Global Tuberculosis Diagnostic Testing Market: US, Europe, Japan-Supplier Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country ... Read More
-
2022-2026 Tuberculosis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Tuberculosis tests performed in the following market segments: Hospitals Commercial/Private Labs ... Read More
-
Europe Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Method (Normal Sized Needles, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)
... (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others) The Europe intradermal injections market is expected to reach US$ 2,131.1 million by 2028 from US$ 1,029.4 million in 2021; it is estimated to grow at ... Read More
-
Middle East and Africa Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Method (Normal Sized Needles, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)
... Others), End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others) The Middle East & Africa intradermal injections market is expected to reach US$ 302.3 million by 2028 from US$ 139.1 million in 2021; ... Read More
-
North America Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Method (Normal Sized Needles, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)
... User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others) The North America intradermal injections market is expected to reach US$ 2,859.3 million by 2028 from US$ 1,342.5 million in 2021; it is estimated to ... Read More
-
2022-2026 Succeeding in the Global Tuberculosis (TB) Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and ... Read More
-
Lateral Flow Assays Market Size By Product (Kits, Readers), By Application (Infectious Disease Testing {Influenza, STDs, Hepatitis, Tuberculosis}, Cardiac Metabolic Testing {CK-MB Testing, Myoglobin, D-dimer, Troponin I}, Pregnancy & Fertility Testing {Pregnancy Testing, Fertility Testing}, Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share ... Read More
-
Tuberculosis - Pipeline Insight, 2022
... It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Tuberculosis Understanding Tuberculosis: Overview Tuberculosis ... Read More
-
Global Latent Tuberculosis Infection (LTBI) Testing Market, 2021-2027
... disease. According to Gen Consulting Company, the global latent tuberculosis infection (LTBI) testing market size is expected to increase from USD 1,344 million in 2020 to USD 1,942 million by 2027, garnering a CAGR of ... Read More
-
2022-2026 Global Respiratory Disease Testing Market--US, Europe, Japan--Shares and Segment Forecasts--Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... of the global respiratory disease testing market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. The report is available by section, and can ... Read More
-
2022-2026 France Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. About this Report This report presents detailed analysis of the Respiratory Disease market in ... Read More
-
2022-2026 Europe Respiratory Disease Testing Market--France, Germany, Italy, Spain, UK--Shares and Segment Forecasts--Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... provides analysis of the European respiratory disease testing market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. The report is available by section, ... Read More
-
2022-2026 Italy Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. About this Report This report presents detailed analysis of the Respiratory Disease market in ... Read More
-
2022-2026 Germany Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. About this Report This report presents detailed analysis of the Respiratory Disease market in ... Read More
-
2022-2026 UK Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. About this Report This report presents detailed analysis of the Respiratory Disease market in ... Read More
-
2022-2026 USA Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis
... market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors. About this Report This report presents detailed analysis of the Respiratory Disease market in ... Read More
-
Global Respiratory Equipment Market: Size & Forecast with Impact Analysis of COVID-19 (2022-2026 Edition)
... an in-depth analysis of the global respiratory equipment market including a detailed description of the impact of COVID-19, market sizing and growth. The analysis includes the market by value and market share by segment, by ... Read More
-
Molecular Diagnostics Market Size By Product (Instruments, Reagents & Kits), By Technology (Polymerase Chain Reaction [PCR], Hybridization, Sequencing, Isothermal Nucleic Acid Amplification Technology [INAAT], Microarrays), By Application (Infectious Disease Diagnostics {COVID-19, HIV, CT/NG, Hepatitis B, Hepatitis C, RSV, Flu, Tuberculosis}, Oncology Testing, Genetic Disease Testing), By End-use (Diagnostics Laboratories, Hospitals & Clinics), Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028
... Hepatitis C, RSV, Flu, Tuberculosis}, Oncology Testing, Genetic Disease Testing), By End-use (Diagnostics Laboratories, Hospitals & Clinics), Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028 ... Read More
-
Infection Surveillance Solutions Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... by 2026, at a CAGR of 12.50% over the forecast period (2021 - 2026). Hospital-associated infections in a clinical setting, such as surgical site infections, urinary tract infection, etc., have prompted healthcare professionals to adopt ... Read More
-
Global Inhaled Nitric Oxide Delivery Systems Market Size study, by Type (General Type, Intelligent Type), Application (Neonatal Respiratory Treatment, COPD, Malaria Treatment, Tuberculosis Treatment, ARDS, Chronic Wound Healing), by End-User (Hospitals, Specialty Clinics, Healthcare Centers) and Regional Forecasts 2021-2027
... and Regional Forecasts 2021-2027 Global Inhaled Nitric Oxide Delivery Systems Market is valued approximately at USD XXX billion in 2020 and is anticipated to grow with a healthy growth rate of more than xxx over ... Read More
-
Global Antimicrobial Resistance Market Report, by Drug Class, By Disease Type, By Pathogen Type, By End-user and Region, Trends & Growth Opportunity and Forecast – 2030
... 16.4 Bn by 2030 According to SPER Market Research, the global antimicrobial resistance market (AMR) was valued at USD 10.2 Bn in 2021 and estimated to reach USD 16.4 Bn by 2030 with a CAGR ... Read More
-
The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
... have fully assessed the in vitro diagnostic market from scratch and re-report numbers. Last year, the COVID-19 pandemic highlighted how important testing is in a way that could not be imagined. This year, COVID-19 is ... Read More
-
Emerging Infectious Disease Diagnostics: Markets and Trends
... preparation for a viral epidemic. He predicted that it would be “microbes, not missiles” that would cause significant harm to humans. Events in recent years have proven him right. Outbreaks of infections such as Zika ... Read More
Research Assistance
